REGISTERING LONG-TERM TRENDS

摘要

Now the trials of Gardasil and Cervarix have formally ended, participants are back with their normal healthcare systems for routine cervical cancer screening and care. But those in Scandinavian countries such as Finland and Sweden can continue to provide information. These countries run national registries that routinely gather data on conditions such as autoimmune disease, pregnancy outcomes and cancer that are linked to personal identification numbers, helping researchers gather long-term vaccine efficacy data against cervical cancer and other HPV-related diseases. "Finland is a paradise of